JP2023552554A5 - - Google Patents
Info
- Publication number
- JP2023552554A5 JP2023552554A5 JP2023534111A JP2023534111A JP2023552554A5 JP 2023552554 A5 JP2023552554 A5 JP 2023552554A5 JP 2023534111 A JP2023534111 A JP 2023534111A JP 2023534111 A JP2023534111 A JP 2023534111A JP 2023552554 A5 JP2023552554 A5 JP 2023552554A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- pharmaceutical composition
- level
- composition according
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063121973P | 2020-12-06 | 2020-12-06 | |
| US63/121,973 | 2020-12-06 | ||
| US202163272629P | 2021-10-27 | 2021-10-27 | |
| US63/272,629 | 2021-10-27 | ||
| US202163275344P | 2021-11-03 | 2021-11-03 | |
| US63/275,344 | 2021-11-03 | ||
| PCT/US2021/062078 WO2022120292A1 (en) | 2020-12-06 | 2021-12-06 | Treatment of hemophilia with fitusiran |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023552554A JP2023552554A (ja) | 2023-12-18 |
| JP2023552554A5 true JP2023552554A5 (cg-RX-API-DMAC7.html) | 2024-12-13 |
Family
ID=80112089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023534111A Pending JP2023552554A (ja) | 2020-12-06 | 2021-12-06 | フィツシランを用いた血友病の処置 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240027478A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4255566A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023552554A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230117403A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021391951A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3204344A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL303452A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023006651A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202237151A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022120292A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3258425A1 (en) * | 2022-06-08 | 2023-12-14 | Genzyme Corporation | Treatment of hemophilia with fitusiran in pediatric patients |
| EP4612687A1 (en) | 2022-11-02 | 2025-09-10 | Genzyme Corporation | Systems and methods for modeling thrombin-antithrombin |
| TW202525306A (zh) * | 2023-09-15 | 2025-07-01 | 美商健臻公司 | 用非妥西蘭(fitusiran)治療a型血友病 |
| WO2025171279A1 (en) * | 2024-02-09 | 2025-08-14 | Genzyme Corporation | Treatment of hemophilia with fitusiran |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9127274B2 (en) | 2012-04-26 | 2015-09-08 | Alnylam Pharmaceuticals, Inc. | Serpinc1 iRNA compositions and methods of use thereof |
| IL308717A (en) | 2015-12-07 | 2024-01-01 | Genzyme Corp | Methods and compositions for treating a serpinc1-associated disorder |
| JP2020530442A (ja) * | 2017-07-10 | 2020-10-22 | ジェンザイム・コーポレーション | 血友病を有する対象の出血事象を処置するための方法および組成物 |
-
2021
- 2021-12-06 KR KR1020237022579A patent/KR20230117403A/ko active Pending
- 2021-12-06 TW TW110145480A patent/TW202237151A/zh unknown
- 2021-12-06 IL IL303452A patent/IL303452A/en unknown
- 2021-12-06 WO PCT/US2021/062078 patent/WO2022120292A1/en not_active Ceased
- 2021-12-06 US US18/256,199 patent/US20240027478A1/en active Pending
- 2021-12-06 EP EP21841061.1A patent/EP4255566A1/en active Pending
- 2021-12-06 JP JP2023534111A patent/JP2023552554A/ja active Pending
- 2021-12-06 CA CA3204344A patent/CA3204344A1/en active Pending
- 2021-12-06 MX MX2023006651A patent/MX2023006651A/es unknown
- 2021-12-06 AU AU2021391951A patent/AU2021391951A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Reasbeck et al. | Double-blind controlled trial of indomethacin as an adjunct to narcotic analgesia after major abdominal surgery | |
| US5145852A (en) | Vaso-active medicament to treat impotence | |
| Chaowagul et al. | A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis | |
| CA2867343C (en) | Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration | |
| KR102438597B1 (ko) | 항종양제의 투여 방법 | |
| JP2018531605A5 (cg-RX-API-DMAC7.html) | ||
| JP2019501886A5 (cg-RX-API-DMAC7.html) | ||
| Fontana et al. | Direct oral anticoagulants: a guide for daily practice | |
| JP2008539273A5 (cg-RX-API-DMAC7.html) | ||
| JP2023552554A (ja) | フィツシランを用いた血友病の処置 | |
| Songdej et al. | Combined chelation therapy with daily oral deferiprone and twice-weekly subcutaneous infusion of desferrioxamine in children with β-thalassemia: 3-year experience | |
| RU2007101686A (ru) | Комбинированная композиция | |
| Krivokuca et al. | Recurrent pulmonary embolism associated with a hemostatic drug: tranexamic acid. | |
| Jerums et al. | Long‐term renoprotection by perindopril or nifedipine in non‐hypertensive patients with type 2 diabetes and microalbuminuria | |
| CN115052628A (zh) | 抗pd-1抗体在治疗肿瘤中的用途 | |
| JP2021152002A5 (cg-RX-API-DMAC7.html) | ||
| JP6885649B2 (ja) | 統合失調症の治療のためのイロペリドン | |
| EP4536246A2 (en) | Fitusiran for the treatment of hemophilia a and b in pediatric patients | |
| Farkas et al. | Home treatment of attacks with conestat alfa in hereditary angioedema due to C1-inhibitor deficiency. | |
| CN116157119A (zh) | 一种ARNi与钙离子拮抗剂的药物组合物与应用 | |
| Michot et al. | A double-blind clinical trial to determine if an interaction exists between diclofenac sodium and the oral anticoagulant acenocoumarol (nicoumalone) | |
| JP2019001830A (ja) | 医薬 | |
| JP2008539265A5 (cg-RX-API-DMAC7.html) | ||
| Grothey | Optimal use of Regorafenib: Dosing strategies and patient selection | |
| Bliding | Efficacy of antianxiety drug therapy in alcohol post-intoxication symptoms: a double-blind study of chlorprothixen, oxazepam and placebo |